AOD9604 CAS:221231-10-3

    AOD9604 (Advanced Obesity Drug) is a synthetic peptide derived from human growth hormone (HGH). Specifically, it incorporates the C-terminal fragment of HGH (amino acids 176-191), responsible for its fat-reducing properties. Unlike HGH, AOD9604 does not have significant effects on growth or blood glucose levels. Its development was initially focused on obesity management, but it has since gained traction in the fitness industry for its potential to aid fat loss and improve body composition without many of the side effects associated with traditional growth hormones.

    AOD9604 works by stimulating lipolysis (the breakdown of fat) and inhibiting lipogenesis (the formation of fat), making it a targeted agent for fat metabolism enhancement.

 

    1.Selective Fat Reduction

    ●Targets adipose tissue without impacting lean muscle mass or other HGH-mediated processes.

    2.Non-Growth Hormonal

    ●Does not affect insulin levels, growth factors, or blood sugar levels, reducing the risk of metabolic disturbances.

    3.High Safety Profile

    ●Demonstrates a lower risk of side effects compared to full-spectrum growth hormones, making it suitable for long-term use.

    4.Convenient Administration

    ●Typically administered via subcutaneous injection, with oral and transdermal formulations under research.

    5.Broad Applicability

    ●Useful in both fitness contexts and medical treatments for obesity and metabolic disorders.

    1.Fat Loss

    ●AOD9604's primary application is in fat reduction, particularly stubborn fat deposits resistant to traditional diet and exercise.

    2.Cutting Phases in Bodybuilding

    ●Ideal for athletes aiming to reduce body fat while preserving muscle during preparation for competitions.

    3.Metabolic Optimization

    ●Boosts metabolism by enhancing fat oxidation, leading to better energy utilization during workouts.

    4.Injury Recovery Support

    ●May exhibit anti-inflammatory properties, aiding in recovery from injuries or intense training sessions.

    5.Weight Management

    ●Suitable for individuals seeking sustainable weight loss, especially those struggling with metabolic or hormonal barriers.

    1.Targeted Fat Loss

    ●Promotes the breakdown of adipose tissue without affecting lean muscle, making it highly effective for body recomposition.

    2.Enhanced Metabolism

    ●Stimulates metabolic processes, ensuring more efficient energy use and fat oxidation during physical activity.

    3.Minimal Side Effects

    ●Lacks significant impacts on glucose metabolism, growth, or hormone levels, reducing common risks associated with HGH.

    4.Improved Recovery

    ●May support tissue repair and reduce inflammation, enhancing recovery from workouts or injuries.

    5.Flexibility in Use

    ●Can be used by a wide range of individuals, from professional athletes to recreational fitness enthusiasts, due to its high safety profile.

    6.Stubborn Fat Reduction

    ●Particularly effective against localized fat deposits, such as abdominal or thigh fat, that are resistant to diet and exercise.

    7.Cardiovascular Support

    ●By reducing visceral fat, AOD9604 may lower the risk of cardiovascular issues and improve overall heart health.

    AOD9604 is most commonly administered via subcutaneous injection, though alternative methods are under investigation.

    1.Dosage Range

    ●Standard dosages range from 200 mcg to 500 mcg daily, depending on individual goals and tolerance.

    2.Frequency

    ●Typically taken once daily, preferably in the morning to align with natural metabolic cycles.

    3.Duration of Use

    ●AOD9604 is often used in cycles of 8–12 weeks, followed by a rest period to assess progress and reset sensitivity.

    4.Administration Site

    ●Subcutaneous injections are commonly delivered into fatty tissue areas, such as the abdomen, for localized effects.

    5.Supplementation

    ●Works well alongside a balanced diet and consistent exercise routine for optimal results.

    1.Standard Fat Loss Cycle (8 Weeks)

    ●Dosage: 300 mcg daily

    ●Purpose: Gradual fat reduction and improved metabolism.

    2.Intensive Fat Loss Cycle (12 Weeks)

    ●Dosage: 500 mcg daily

    ●Purpose: Accelerated fat loss for cutting phases or stubborn fat reduction.

    3.Maintenance Cycle (4–6 Weeks)

    ●Dosage: 200 mcg daily

    ●Purpose: Sustain results achieved during a prior fat loss cycle.

    4.Stacking Options

    ●AOD9604 can be stacked with other peptides like CJC-1295 or Ipamorelin for synergistic effects on fat loss and recovery.

    The half-life of AOD9604 is approximately 4 hours, necessitating daily administration for sustained effects. Its short half-life allows for precise control over dosing and minimizes long-term accumulation in the body.

    As AOD9604 does not interfere with hormonal pathways, traditional post-cycle therapy (PCT) involving hormone regulation is unnecessary. However, certain steps can enhance post-cycle benefits:

    1.Nutritional Optimization

    ●Maintain a calorie-controlled diet rich in proteins, healthy fats, and fiber to sustain fat loss.

    2.Continued Physical Activity

    ●Regular exercise ensures long-term metabolic benefits and prevents rebound fat gain.

    3.Hydration and Recovery

    ●Proper hydration and adequate rest are essential for maintaining results and supporting recovery.

    4.Periodic Monitoring

    ●Regularly track body composition, metabolic markers, and overall health to ensure sustainable progress.

    While AOD9604 is well-tolerated, minor side effects have been reported in some individuals:

    1.Injection Site Reactions

    ●Temporary redness, swelling, or irritation may occur at the injection site.

    2.Digestive Distress

    ●Some users report mild nausea or gastrointestinal discomfort.

    3.Fatigue

    ●Initial use may cause slight lethargy as the body adapts to increased fat metabolism.

    4.Allergic Reactions

    ●Rare cases of hypersensitivity to the peptide have been documented.

Aspect	AOD9604	HGH	Clenbuterol	Traditional Fat Burners
Mechanism	Targets Lipolysis	Broad Spectrum Effects	Stimulant-driven Fat Loss	Stimulant-driven Fat Loss
Fat Specificity	High	Moderate	Moderate	Low
Side Effect Profile	Low	Moderate to High	High	Moderate to High
Non-Stimulant	Yes	No	No	No

    Studies have shown that AOD9604 effectively stimulates fat metabolism without the adverse effects typically associated with growth hormone therapies. Anecdotal evidence from athletes and fitness enthusiasts suggests noticeable reductions in stubborn fat deposits, improved energy levels, and better overall body composition.

Product Name	Fragment 177-191; AOD 9604 acetate; peptides AOD9604; Peptide HGH 176-191; polypeptide AOD 9604; HGH frag 176-191 Oxidized
CAS	221231-10-3
Molar mass	1815.1
MF	C78H123N23O23S2
Capacity/Bottle	2mg/vial
Shape	Lyophilized powder

 

Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885

 

    AOD9604 offers a novel and targeted approach to fat loss, leveraging the benefits of HGH-derived peptides without the associated risks. Its selective action on adipose tissue, combined with a favorable safety profile, makes it an attractive option for athletes, bodybuilders, and anyone seeking to enhance their physique or metabolic health.

    By incorporating AOD9604 into a well-rounded fitness regimen, individuals can achieve sustainable fat loss, improved recovery, and enhanced overall performance. However, as with any supplement, it should be used responsibly and under professional guidance to maximize benefits while minimizing risks.

 

Hot Tags: AOD9604 CAS:221231-10-3, China AOD9604 CAS:221231-10-3 manufacturers, suppliers, factory